Annual Operating Margin
-56.13%
+67.80%+54.71%
April 30, 2024
Summary
- As of February 8, 2025, IPA annual operating profit margin is -56.13%, with the most recent change of +67.80% (+54.71%) on April 30, 2024.
- During the last 3 years, IPA annual operating margin has fallen by -32.82% (-140.80%).
- IPA annual operating margin is now -140.80% below its all-time high of -23.31%, reached on April 30, 2021.
Performance
IPA Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-46.02%
+41.90%+47.66%
October 31, 2024
Summary
- As of February 8, 2025, IPA quarterly operating profit margin is -46.02%, with the most recent change of +41.90% (+47.66%) on October 31, 2024.
- Over the past year, IPA quarterly operating margin has increased by +41.90% (+47.66%).
- IPA quarterly operating margin is now -185.25% below its all-time high of 53.98%, reached on September 30, 2008.
Performance
IPA Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
IPA Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.7% | +47.7% |
| 3 y3 years | -140.8% | +47.7% |
| 5 y5 years | +1.5% | +47.7% |
IPA Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -140.8% | +54.7% | -0.9% | +78.0% |
| 5 y | 5-year | -140.8% | +54.7% | -1763.2% | +78.0% |
| alltime | all time | -140.8% | +100.0% | -185.3% | +100.0% |
ImmunoPrecise Antibodies Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | -46.02%(-47.7%) |
| Jul 2024 | - | -87.92%(+61.5%) |
| Apr 2024 | -56.13%(-54.7%) | -54.44%(+1.4%) |
| Jan 2024 | - | -53.69%(+17.7%) |
| Oct 2023 | - | -45.61%(-31.1%) |
| Jul 2023 | - | -66.21%(+8.2%) |
| Apr 2023 | -123.93%(+43.9%) | -61.22%(-30.6%) |
| Jan 2023 | - | -88.15%(-41.5%) |
| Oct 2022 | - | -150.66%(-27.9%) |
| Jul 2022 | - | -209.04%(+156.6%) |
| Apr 2022 | -86.10%(+269.4%) | -81.47%(-8.2%) |
| Jan 2022 | - | -88.70%(-10.3%) |
| Oct 2021 | - | -98.88%(+34.4%) |
| Jul 2021 | - | -73.56%(+45.2%) |
| Apr 2021 | -23.31%(-14.4%) | -50.65%(+139.7%) |
| Jan 2021 | - | -21.13%(+52.5%) |
| Oct 2020 | - | -13.86%(+461.1%) |
| Jul 2020 | - | -2.47%(-91.2%) |
| Apr 2020 | -27.22%(-52.2%) | -28.15%(+474.5%) |
| Jan 2020 | - | -4.90%(-84.4%) |
| Oct 2019 | - | -31.36%(-42.0%) |
| Jul 2019 | - | -54.11%(-58.2%) |
| Apr 2019 | -56.97%(-34.9%) | -129.49%(+318.7%) |
| Jan 2019 | - | -30.93%(-26.1%) |
| Oct 2018 | - | -41.83%(+43.9%) |
| Jul 2018 | - | -29.06%(-72.3%) |
| Apr 2018 | -87.49%(+74.0%) | -104.94%(+67.6%) |
| Jan 2018 | - | -62.62%(-11.0%) |
| Oct 2017 | - | -70.37%(-51.3%) |
| Jul 2017 | - | -144.64%(-16.7%) |
| Apr 2017 | -50.29% | -173.65%(+51.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2017 | - | -114.68%(-312.4%) |
| Sep 2008 | - | 53.98%(-151.7%) |
| Sep 2007 | - | -104.46%(-97.8%) |
| Jun 2006 | - | -4745.85%(+2709.2%) |
| Sep 2005 | - | -168.94%(-84.9%) |
| Jun 2005 | - | -1118.53%(+14.3%) |
| Jun 2004 | - | -978.52%(-98.8%) |
| Dec 2001 | -50.30 K%(+11.6%) | - |
| Jun 2001 | - | -80.57 K%(-96.9%) |
| Mar 2001 | - | -2.58 M%(>+9900.0%) |
| Dec 2000 | -45.08 K%(+1839.2%) | - |
| Dec 2000 | - | -12.69 K%(-99.4%) |
| Sep 2000 | - | -2.24 M%(-13.2%) |
| Jun 2000 | - | -2.58 M%(+6.1%) |
| Mar 2000 | - | -2.43 M%(>+9900.0%) |
| Dec 1999 | -2324.42%(+584.3%) | - |
| Dec 1999 | - | -401.51%(-100.0%) |
| Sep 1999 | - | -2.60 M%(-28.6%) |
| Jun 1999 | - | -3.64 M%(+2.7%) |
| Mar 1999 | - | -3.54 M%(>+9900.0%) |
| Dec 1998 | -339.67%(-99.9%) | - |
| Dec 1998 | - | -36.09%(-100.0%) |
| Sep 1998 | - | -3.20 M%(-25.9%) |
| Jun 1998 | - | -4.32 M%(+25.6%) |
| Mar 1998 | - | -3.44 M%(+2593.6%) |
| Dec 1997 | -479.57 K%(>+9900.0%) | - |
| Dec 1997 | - | -127.71 K%(-96.6%) |
| Sep 1997 | - | -3.70 M%(-53.4%) |
| Jun 1997 | - | -7.95 M%(+138.2%) |
| Mar 1997 | - | -3.34 M% |
| Dec 1996 | -3396.15% | - |
FAQ
- What is ImmunoPrecise Antibodies annual operating profit margin?
- What is the all time high annual operating margin for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual operating margin year-on-year change?
- What is ImmunoPrecise Antibodies quarterly operating profit margin?
- What is the all time high quarterly operating margin for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly operating margin year-on-year change?
What is ImmunoPrecise Antibodies annual operating profit margin?
The current annual operating margin of IPA is -56.13%
What is the all time high annual operating margin for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual operating profit margin is -23.31%
What is ImmunoPrecise Antibodies annual operating margin year-on-year change?
Over the past year, IPA annual operating profit margin has changed by +67.80% (+54.71%)
What is ImmunoPrecise Antibodies quarterly operating profit margin?
The current quarterly operating margin of IPA is -46.02%
What is the all time high quarterly operating margin for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly operating profit margin is 53.98%
What is ImmunoPrecise Antibodies quarterly operating margin year-on-year change?
Over the past year, IPA quarterly operating profit margin has changed by +41.90% (+47.66%)